Key result
Recent advances clarify influenza-associated pathogenesis and treatment among Japan's ~1,000 annual infantile viral encephalitis cases.
Why the study?
There is no available information regarding the causative agent, prognosis, pathogenesis, and treatment of infantile viral encephalitis and encephalopathy in Japan except for HSV and influenza encephalopathy.
This review summarizes recent advances from Japanese research programs on influenza and other encephalopathies in infants.
Answers are grounded in this paper and cite their sources.
Japanese research advances extend influenza encephalopathy insights; leaves open etiology, prognosis, and management for other infantile viral cases.
It has been reported that there are approximately one thousand annual cases of infantile viral encephalitis and encephalopathy in Japan. There are, however, no available information regarding its causative agent, prognosis, pathogenesis, and treatment except for HSV and influenza encephalopathy. Here, I review the recent advances from the two research programs on influenza and other encephalopathy in Japan supported by MEXT and MHLW.
No takes yet. Share an insight, caveat, or question.
Tsuneo Morishima (2009) conducted a review in Infantile viral encephalitis and encephalopathy. There are approximately 1,000 annual cases of infantile viral encephalitis and encephalopathy in Japan, with recent advances clarifying the pathogenesis and treatment of influenza-associated cases.
Synapse has enriched 10 related papers. Consider them for comparative context: